DeepNiche

CRISPR in the clinic

Scribe starts first-in-human STX-1150 trial

The Phase 1 opened in Australia in mid-2026 in adults with elevated LDL-C and increased ASCVD risk.

source: The Biotech Times

Get DeepNiche

The full briefing is in the app.

More CRISPR in the clinic clippings